Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR

Associates of Cape Cod, Inc.

E Falmouth, MA, US

ASSOCIATES OF CAPE COD, INC. appears in FDA device records in E Falmouth, MA. FDA records list 2 510(k) clearances between and , no PMA records and one registered establishment. As of , FDA records show 2 recalls for this company, and at least one establishment registration is current.

FDA records held for this company

510(k) clearances
2
PMA records
0
Recall records
2
Registered establishments
1

510(k) clearance history

FDA records hold 2 510(k) clearances for Associates of Cape Cod, Inc. between 2004 and 2019. The busiest year on record is 2004, with 1. The most recent is 2019, with 1.

Clearances by year, as a table
510(k) clearance decisions for Associates of Cape Cod, Inc., by decision year
YearClearances
20041
20191
510(k) clearances on record, most recent first
K numberDeviceProduct codeDecisionDecision date
K191167Fungitell STATNQZSubstantially Equivalent
DEN040003GLUCATELLNQZUnknown

Registered establishments

FDA registered establishments for Associates of Cape Cod, Inc., with the product codes listed at each
RegistrationFEIEstablishmentAddressRegistration expiresProduct codes listed
12191451219145ASSOCIATES OF CAPE COD, INC.124 Bernard E. Saint Jean Drive, E Falmouth, MA 02536 US2026

Registration numbers link to the FDA registration and listing record for that establishment.

FDA product codes

Recall records

Device recall records naming this company, most recent first
RecallProductReasonClassificationInitiatedStatus
Z-1774-2022Fungitell STAT- IVD Assay for (1 3)-~-D-Glucan in Serum Ref: FT007Incorrect information on the Fungitell STAT clamshells containing the Fungitell STAT Standard, relates to printed information for reconstitution and pretreatment volumesClass IITerminated
Z-1329-2019Fungitell Kit, Catalog FT001 - Product Usage: The Fungitell assay is a potease zymogen-based colorimetric assay for the qualitative detection of (1-3)Beta-D Glucan in the serum of patients with symptoms of,or medical conditions predisposing the patient to, invasive fungal infection. The serum concentration of (1-3)Beta-D Glucan, a major cell wall component of various medically important fungi, can be used as an aid in teh diagnosis of deep-seated mycoses and funemias. A positve result does not indicate which genus of fungi may be causing the infection. (1-3)Beta-D Glucan titers should be used in conjunction with other diagnostic procedures, such as microbiological culture, histological examination of biopsy samples and radiological examination.The kits may contain the incorrect number of components or the kits may be missing components.Class IITerminated

Verification record

There is no verification record for this company. Most companies on this site have none: a record exists only where a company asked to be verified and MDM ran the checks, so the absence of one says nothing about the company.

Where there is a record, this is where it appears: what was checked, when it was checked, and the current status. An MDM Verified badge on another website links to a verify address on this domain that resolves to this section. A badge that does not resolve here is not ours.

What MDM checks, and what it does not

MDM coverage

MDM coverage of this company lists here, newest first. Submit news.

Is this your company?

This page is built from public FDA records. Company pages are free and factual, and stay free whether or not anyone claims them. Membership never changes editorial coverage or vetting outcomes.

Claiming lets Associates of Cape Cod, Inc. edit what it says about itself and list the categories it works in. It grants no badge: claiming is not verification.

Claim this page

Data as of , FDA export datePage updated Source: openFDA, public domain